Header Logo

Connection

Caleb Scheckel to Biosimilar Pharmaceuticals

Back to Details
This is a "connection" page, showing publications Caleb Scheckel has written about Biosimilar Pharmaceuticals.
Caleb Scheckel
Connection Strength
0.972
Biosimilar Pharmaceuticals
  1. Generics and Biosimilars: Barriers and Opportunities. Mayo Clin Proc. 2021 12; 96(12):2947-2957.
    View in: PubMed
    Score: 0.763
  2. Neulasta Onpro: a coup de gr?ce? Am J Manag Care. 2023 03 01; 29(3):e69-e70.
    View in: PubMed
    Score: 0.209
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.